Savara Inc. (SVRA) Stock News & Chart | StockAdder

(SVRA)

Savara Inc.

Stock chart and latest news for Savara Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Savara Inc. News

PRO

Savara brings new rare lung disease data to 3 ATS presentations

Apr 14, 2026 simplywall.st

Savara (SVRA) Is Up 6.5% After Multi-Region Accelerated Reviews Granted for MOLBREEVI Therapy

Apr 9, 2026 Yahoo Finance

What Does Wall Street Think About Savara Inc. (SVRA)?

Oct 30, 2025 Business Wire

Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants

Oct 29, 2025 Seeking Alpha

Savara Stock: A High-Risk Opportunity (NASDAQ:SVRA)

Nov 16, 2025 MarketBeat

Savara Inc. (NASDAQ:SVRA) Receives Consensus Rating of "Moderate Buy" from Brokerages

Mar 27, 2026 Investing.com

Citizens reiterates Savara stock rating on likely FDA approval

Feb 23, 2026 Stock Titan

Savara Inc. (NASDAQ: SVRA) proxy: MOLBREEVI FDA date, equity and vote items

Apr 10, 2026 StocksToTrade

Savara Stock: Will It Continue to Rise?

Nov 28, 2025 timothysykes.com

Savara Stock Surges Amid Positive Financial Developments and Raised Price Target

Nov 30, 2025 Yahoo Finance

Savara Inc. (SVRA) Upgraded to Buy After FDA CMC Breakthrough

Aug 23, 2025 Business Wire

Savara Announces Proposed Public Offering